A Four-Week Multicenter Study Evaluating the Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Subjects With Osteoarthritis of the Knee
Clinical trial NCT01554579 · COMPLETED
Trial details
- NCT number
- NCT01554579
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-29
- Primary completion
- 2013-11-11
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.